STATE OF OKLAHOMA 2013 EMERGENCY MEDICAL SERVICES PROTOCOLS 16A – ALBUTEROL (PROVENTIL®, VENTOLIN®) EMERGENCY MEDICAL DISPATCHER
Self-Administration Phone Directive - 3B 3C 3D 12B
Assist Pt with Self Administration - 3B 3C 3D 12B
RESPONDER EMT-INTERMEDIATE 85 ADVANCED EMT PARAMEDIC Class: Sympathomimetic Bronchodilator Actions/Pharmacodynamics: Albuterol is a relatively selective beta2 adrenergic stimulant.
Albuterol causes relaxation of the smooth muscles of the bronchial tree thus decreasing airway
resistance, facilitating mucus drainage, and increasing vital capacity. It exerts mild effects on
beta1 (heart) or alpha (peripheral vasculature) receptors. In therapeutic doses, albuterol, by
inhibiting histamine release from mast cells, also reduces the mucus secretion, capil ary leaking,
and mucosal edema caused by an allergic response in the lungs.
Indications: Dyspnea - Uncertain Etiology (3B)
Dyspnea - Chronic Obstructive Pulmonary Disease (3D)
Contraindications: Known hypersensitivity to albuterol. Albuterol should not be used if the
sole etiology of dyspnea is strongly suspected to be CHF, as albuterol-induced tachycardia may
worsen the compromised cardiac output in CHF.
Pharmacokinetics: Onset within 5 – 15 minutes; peak effect in 1 – 1.5 hours; duration of effect
is up to 3 – 6 hours; half – life is less than 3 hours. Distribution: When inhaled, albuterol is
distributed to muscle cells along the bronchial tree. Very little is systemically absorbed and
Side Effects: Tremors, anxiety, dizziness, headache, cough, reflex bronchospasm, palpitations, STATE OF OKLAHOMA 2013 EMERGENCY MEDICAL SERVICES PROTOCOLS
Peter Satterthwaite Senior Portfolio Manager Capital & Coast District Health Board Private Bag 7902 WELLINGTON To: C&C DHB BOARD Through: Margot Date: May Subject: Resource Allocation & Cardiovascular Resource Allocation EXECUTIVE SUMMARY In October 2002 the Board asked CPHAC (its Community and Public Health Advisory Committee) to begin a program
Productos estériles preparados en farmaciaMedicamentos que requieren autorización para ser solicitadosControl de Infecciones Intrahospitalarias, Productos Farmacéuticos y Normas Transfusionales PRODUCTOS FARMACÉUTICOS DISPONIBLES ACIDO FOLÍNICO 3mg-50mg “LEUCOVORINA” ACIDO TRANEXÁMICO 1G Directo y lento (1 g en 5 min) Utilizar inmediatamente una vez ACYCLOVIR 250MG ADEN